Combination of EUTOS score and 3-month BCR-ABL transcript level identifies a group of good-risk chronic myeloid leukemia patients with favorable response to frontline imatinib therapy.
作者信息
Tiribelli Mario, Binotto Gianni, Calistri Elisabetta, Maino Elena, Scaffidi Luigi, Medeot Marta, Nabergoj Mitja, Ambrosetti Achille, Semenzato Gianpietro, Fanin Renato, Bonifacio Massimiliano
机构信息
Division of Hematology and BMT, Department of Experimental and Clinical Medical Sciences, Azienda Ospedaliero-Universitaria, Udine, Italy.
Padua School of Medicine, Department of Medicine, Hematology and Clinical Immunology, Padua, Italy.
出版信息
Am J Hematol. 2015 Jul;90(7):E135-7. doi: 10.1002/ajh.24022. Epub 2015 May 28.
PMID:25808917
Abstract
摘要
Zotero 插件